Gapping up
In reaction to strong earnings/guidance:
- ADNT +23.4%, AMZN +10.8%, FLEX +10.6%, BERY +10%, NATI +9.8%, WDC +4.9%, CL +4.7%, DECK +3.9%, EW +3.8%, X +3.7%, VRTX +3.6%, OTEX +3.4%, RHI +3.1%, SIGI +2.9%, RMD +2.7%, SKYW +1.9%, JCI +1.2%, KKR +1.2%, MAN +1.1%, AJG +0.8%, JOUT +0.8%, AON +0.7%
M&A news:
- NAV +55.9% (receives $35/sh takeover bid from Volkswagen subsidiary)
Other news:
- IBM +4% (IBM names Arvind Krishna as CEO)
- ESPR +3.5% (receives positive CHMP opinion for the MAA for the bempedoic acid tablet, recommending approval for the treatment of hypercholesterolemia and mixed dyslipidemia)
- TELL +3% (announces that LNG has dismissed all claims against TELL)
- DBX +2.1% (names new COO)
- NXST +1.3% (increases quarterly cash dividend to $0.56 per share from $0.45 per share)
- NVO +0.9% (Rybelsus recommended for approval for the treatment of adults with type 2 diabetes by the European regulatory authorities)
Analyst comments:
- DECK +4% (upgraded to Buy from Hold at Jefferies)
- ARNA +2.6% (upgraded to Overweight from Neutral at JP Morgan)
- CTVA +1.3% (upgraded to Neutral from Underweight at JP Morgan)
- MO +0.8% (upgraded to Overweight from Neutral at Piper Sandler)